Clinical trial NCT04300868 - References

Multiple Sclerosis — Immunisation Status and Safety of Vaccines in Italian MS Patients

Citation(s)

•   • Yang SH, Hsu C, Cheng AL, Kuo SH (2014) Anti-CD20 monoclonal antibodies and associated viral hepatitis in hematological diseases
  World J Hematol, 3(2):29-43
•   Cahill JFX, Izzo A, Garg N (2010) Immunisation in patients with Multiple Sclerosis
  Neurol. Bull, 2:17-21. 10.7191/neurol_bull.2010.1020
•   Farez MF, Correale J
  Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol. 2011 Oct;68(10):1267-71. doi: 10.1001/archneurol.2011.131. Epub 2011 Jun 13.
•   Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R; ITANG study group
  Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. Eur J Epidemiol. 2013 May;28(5):433-44. doi: 10.1007/s10654-013-9797-8. Epub 2013 Mar 31.
•   Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K
  Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Mult Scler. 2015 Dec;21(14):1823-32. doi: 10.1177/1352458515576984. Epub 2015 Mar 31.
•   Löbermann M, Boršo D, Hilgendorf I, Fritzsche C, Zettl UK, Reisinger EC
  Immunization in the adult immunocompromised host. Autoimmun Rev. 2012 Jan;11(3):212-8. doi: 10.1016/j.autrev.2011.05.015. Epub 2011 May 18. Review.
•   Loebermann M, Winkelmann A, Hartung HP, Hengel H, Reisinger EC, Zettl UK
  Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol. 2012 Jan 24;8(3):143-51. doi: 10.1038/nrneurol.2012.8. Review.
•   Mailand MT, Frederiksen JL
  Vaccines and multiple sclerosis: a systematic review. J Neurol. 2017 Jun;264(6):1035-1050. doi: 10.1007/s00415-016-8263-4. Epub 2016 Sep 7. Review.
•   Montgomery S, Hillert J, Bahmanyar S
  Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol. 2013 Aug;20(8):1153-60. doi: 10.1111/ene.12130. Epub 2013 Mar 16.
•   MS council for clinical practice guideline
  Immunisation and multiple sclerosis. Evidence-Based Management Strategies for Immunisations in Multiple Sclerosis. Nov 2001
•   National MS society Vaccinations https://www
  nationalmssociety.org/Living-Well-With-MS/Diet-Exercise-Healthy-Behaviors/Vaccinations
•   Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AW, Knippenberg K, Schuerch M, Foskett N, LaFleur J
  Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans. Int J MS Care. 2015 Sep-Oct;17(5):221-30. doi: 10.7224/1537-2073.2014-035.
•   Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S, McCready W, Ferroni G, Ulanova M
  Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clin Vaccine Immunol. 2012 May;19(5):766-71. doi: 10.1128/CVI.05675-11. Epub 2012 Mar 7.
•   Olsson T
  The new era of multiple sclerosis therapy. J Intern Med. 2014 Apr;275(4):382-6. doi: 10.1111/joim.12196. Epub 2014 Mar 15.
•   Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L; NeuroNet Study Group
  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner. Ther Adv Neurol Disord. 2014 Mar;7(2):137-49. doi: 10.1177/1756285613501575. Review.
•   Orlicka K, Barnes E, Culver EL
  Prevention of infection caused by immunosuppressive drugs in gastroenterology. Ther Adv Chronic Dis. 2013 Jul;4(4):167-85. doi: 10.1177/2040622313485275.
•   Panitch HS
  Influence of infection on exacerbations of multiple sclerosis. Ann Neurol. 1994;36 Suppl:S25-8.
•   Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS
  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
•   Rutschmann OT, McCrory DC, Matchar DB; Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines
  Immunization and MS: a summary of published evidence and recommendations. Neurology. 2002 Dec 24;59(12):1837-43.
•   Steelman AJ
  Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation. Front Immunol. 2015 Oct 19;6:520. doi: 10.3389/fimmu.2015.00520. eCollection 2015. Review.
•   Vaccines
  gov https://www.vaccines.gov/basics/types/index.html
•   Williamson EM, Berger JR
  Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs. 2015 Mar;29(3):229-44. doi: 10.1007/s40263-015-0226-2. Review.
•   Williamson EM, Chahin S, Berger JR
  Vaccines in Multiple Sclerosis. Curr Neurol Neurosci Rep. 2016 Apr;16(4):36. doi: 10.1007/s11910-016-0637-6. Review.
•   Winkelmann A, Loebermann M, Reisinger EC, Hartung HP, Zettl UK
  Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol. 2016 Apr;12(4):217-33. doi: 10.1038/nrneurol.2016.21. Epub 2016 Mar 4. Review.
•   www
  cdc.gov Adults with chronic conditions: get vaccinated. Available from https://www.cdc.gov/features/vaccineschronicconditions/index.html. Accessed May 13, 2018.
•   www
  ecdc.europa.eu Seasonal influenza vaccines. Influenza vaccination. Available from: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/vaccines/Pages/ influenza_vaccination.aspx#vaccinationstrategies. Accessed May 13, 2018
•   www
  salute.gov Ministero della salute. Vaccinazioni http://www.salute.gov.it/portale/vaccinazioni/homeVaccinazioni.jsp

Immunisation Status Against Major Communicable Diseases Preventable With Vaccines, and Safety of Vaccines, in a Cohort of MS Patients. An Italian Multicenter Study

Details for clinical trial NCT04300868